Financial Health Assessment: SCOTT PROCESS TECHNOLOGY LTD.

1. Financial Health Score: B+ (Stable and Recovering)

The patient exhibits a strong and steady pulse following a period of significant historical contraction. The business is currently lean, debt-free in the long term, and consistently building equity. While it operates at a much smaller scale than it did a decade ago, its current vital signs indicate a stable, low-risk financial condition with healthy liquidity.

2. Key Vital Signs

• Pulse (Liquidity & Working Capital): Strong. The company has a current ratio of approximately 2.0 (£103,776 in current assets vs. £52,108 in current liabilities). For every pound of short-term debt, the business has two pounds of short-term assets to cover it. This indicates a healthy cash flow pulse and no immediate risk of insolvency.
• Blood Pressure (Leverage): Excellent. Total liabilities stand at £52,108, all of which appear to be current (due within one year). There are no long-term debts visible on the balance sheet. The business is operating free from the heavy financial burden of long-term borrowing.
• Immune System (Net Worth): Strengthening. Shareholders' funds have grown consistently from £88,998 in 2019 to £164,547 in 2025. The business is retaining profits and building its financial reserves, making it more resilient to future economic shocks.
• Muscle Mass (Asset Base): Lean but Stabilized. Total assets have shrunk drastically from £1.9M in 2014 to £219k in 2025. However, the bleeding stopped around 2023, and the asset base has stabilized over the last two years, suggesting the business has found its sustainable operating weight.

3. Diagnosis

Looking at the patient's medical history, Scott Process Technology Ltd. underwent a major "surgical restructuring" between 2014 and 2019. During this time, total assets dropped from nearly £2 million to roughly £500k, and net assets fell from £937k to £89k. This historical trauma suggests the business may have sold off significant divisions, written off bad investments, or suffered major trading losses.

However, the current diagnosis is stable and recovering. Since 2019, the company has been quietly and steadily rehabilitating. It operates today as a micro-entity with a single employee. The sharp drop in total assets from 2021 (£508k) to 2025 (£219k) is actually misleading in terms of underlying health; a closer look reveals that liabilities dropped even faster, meaning net assets actually increased during this period. The business has effectively paid down a massive amount of debt (from £266k in 2020 to £52k in 2025). The patient has shed excess weight and is now operating as a lean, self-sufficient micro-enterprise.

4. Recommendations

• Cardiovascular Exercise (Cash Flow Management): With a solid current ratio, the business has good liquidity. However, as a micro-entity with only £103k in current assets, a single bad debt could still cause a stumble. Maintain strict credit control and keep cash buffers healthy to ensure the pulse remains steady.
• Building Muscle (Strategic Reinvestment): The company is generating retained profits but holding most of its value in fixed assets (£115k) rather than cash. Evaluate whether these fixed assets are actively generating returns. If the business is meant to remain a small, specialized consultancy, consider whether some fixed assets could be liquidated to build a stronger cash reserve.
• Preventative Care (Succession Planning): The business is heavily reliant on its director and secretary (Nicholas and Xxxxxx Xxxxxxxxname shown to subscribers), who hold significant control and represent the entire workforce. As a long-standing company (incorporated in 1995), it is vital to have contingency plans in place for management continuity or an orderly wind-down in the future, ensuring the £164k of equity can be realized if the directors choose to step back.

Names of the people mentioned are shown to subscribers. See subscription